1984
DOI: 10.1111/j.1440-1827.1984.tb07594.x
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Cystosarcoma Phyllodes Of Prostate

Abstract: A case of malignant cystosarcoma phyllodes of the prostate is reported in a 45‐year‐old male. This tumor was composed of benign columnar or squamous cystic folds and sarcomatous stroma including rhabdomyomatous elements. The prostatic origin of the tumor was clearly proved by the unlabeled immunoperoxidase method. ACTA PATHOL. JPN. 34: 663–668, 1984.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

1990
1990
2004
2004

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(18 citation statements)
references
References 2 publications
0
18
0
Order By: Relevance
“…Phyllodes tumor is a rare neoplasm of the prostate which may undergo sarcomatous transformation, is prone to early recurrences, infiltrative growth, and has potential for extraprostatic spread. [3][4][5][6][7] Benign clinical courses have been cited, but the follow-up time has been limited. 33 In regards to the stroma, Gaudin et al 34 proposed the clinicopathologic categories of prostatic stromal proliferation of uncertain malignant potential and prostatic stromal sarcoma to differentiate these entities from other mesenchymal lesions of the prostate, using immunohistochemical staining data in conjunction with morphological criteria.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Phyllodes tumor is a rare neoplasm of the prostate which may undergo sarcomatous transformation, is prone to early recurrences, infiltrative growth, and has potential for extraprostatic spread. [3][4][5][6][7] Benign clinical courses have been cited, but the follow-up time has been limited. 33 In regards to the stroma, Gaudin et al 34 proposed the clinicopathologic categories of prostatic stromal proliferation of uncertain malignant potential and prostatic stromal sarcoma to differentiate these entities from other mesenchymal lesions of the prostate, using immunohistochemical staining data in conjunction with morphological criteria.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] The malignant potential of this tumor is unclear and has resulted in confusion in terms of prognosis and treatment. Unquestionably, the potential for sarcomatous transformation, recurrence, and infiltrative growth exists, but the frequency of these changes and their prognostic significance is unclear.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The immunohistochemical profile resembles that of postoperative spindle cell nodules; however, the staining intensity of the different markers (smooth muscle actin, vimentin, cytokeratin) is generally much weaker. A recent immunohistochemical study revealed strong positivity for anaplastic lymphoma kinase in inflammatory myofibroblastic tumors (inflammatory pseudotumors) [7,47]. Ultrastructural studies failed to reveal epithelial differentiation, but showed myofibroblastic differentiation.…”
Section: Pseudosarcomatous Fibromyxoid Tumors and Nodular Spindle Celmentioning
confidence: 93%
“…The stromal cells are positive for vimentin and occasionally also for desmin. The MIB-1 proliferation index is in the range of 10-20% and the mitotic rate increased [47,48].…”
Section: Phyllodes Tumor Of the Prostatementioning
confidence: 99%